HOWL werewolftx.com: Prakiraan rega marang bathi

The recruitment of elite oncobiologists to develop PREDATOR cytokines is driving the publication of test results, which the daily forward P/E chart for Werewolf Therapeutics (HOWL) on GURU.Markets reflects through price action. The value of 0.00 represents the metric's baseline, while the overall financial stability of Werewolf Therapeutics relies exclusively on its ability to attract external capital to fund research.

Werewolf Therapeutics - Pangali mangsa ngarep rega marang bathi HOWL (periode 04.07.2022 - 11.11.2026)

Rincian metrik lan analitis perusahaan Werewolf (HOWL)

- kuotasi lan prakiraan analis:

Rega saham Werewolf Therapeutics|HOWL - Rentang target analis

- data kapitalisasi saham perusahaan:

Biji pasar Werewolf Therapeutics Inc.|HOWL - Total Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi saben Saham Werewolf Therapeutics|HOWL - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku werewolftx.com|HOWL - Gunggung Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Utang marang Ekuitas Werewolf Therapeutics|HOWL - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Werewolf Therapeutics|HOWL - Gunggung utang perusahaan|Utang marang nilai buku Werewolf Therapeutics Inc.|HOWL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Werewolf Therapeutics|Likuiditas cepet werewolftx.com

- rincian asil keuangan lan kelipatan valuasi:

HOWL - Penghasilan resik perusahaan|Bathi mangsa ngarep Werewolf Therapeutics|HOWL - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Werewolf Therapeutics|HOWL - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Werewolf Therapeutics Inc.|HOWL - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Werewolf Therapeutics|HOWL - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan werewolftx.com|HOWL - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Werewolf Therapeutics

Analisis fundamental perusahaan:Werewolf Therapeutics, Inc. HOWL

The development of the PREDATOR platform in the field of targeted immuno-oncology drives the high valuation of Werewolf Therapeutics (HOWL) research and development assets. The forward P/E ratio compares the current market value of the business with projected annual net income, allowing for an assessment of the premium paid for innovation potential via the company's forward P/E chart to identify fair value points.

Analisis perusahaan pesaing